Claudia M. Perez-Kasmarski
FDA Investigator
- Claudia M. Perez-Kasmarski first started conducting FDA inspections in 2019, with the last inspection in 2024. Over that time, Claudia M. Perez-Kasmarski has conducted 23 inspections at 23 companies across 23 sites.
Get Claudia Perez-Kasmarski's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Jiangxi Tianxin Pharmaceutical Co., Ltd., Leping | 2024
Out of stock
FDA 483 Pharmadepot Labs, LLC, San Diego | 2024
Out of stock
FDA 483 RB Salute Mexico SA de CV, Coyoacan | 2023
Out of stock
FDA 483 Laboratorios Liomont, S.A. de C.V., Ciudad De Mexico | 2023
Out of stock
FDA 483 Organo Sintesis, S.A. De C.V., Capulhuac | 2023
Out of stock
FDA 483 Chemcor Chemical Corp, Chino | 2022
Out of stock
FDA 483 O.C.C.S. Inc., Stanton | 2022
Out of stock
FDA 483 Pyramid Laboratories, Inc., Costa Mesa | 2021
Out of stock
FDA 483 Nitto Avecia Pharma Services, Inc, Irvine | 2020
Out of stock
FDA 483 Montalvan's Sales, Inc., Ontario | 2019
Out of stock
Co-Investigators (16)
- Navneet Kaur, FDA Investigator
- Muna Algharibeh, FDA Investigator
- Amir Alavi, FDA Investigator
- Andrew Le, FDA Investigator
- Bryan A. Galvez, FDA Investigator
- Gavin T. Cua, FDA Investigator
- Lisa Shin, FDA Investigator
- Santiago Gallardo Johnson, FDA Investigator
- Miguel A. Martinez, FDA Investigator
- Scott N. Lim, FDA Investigator
- Alan L. Truong, FDA Investigator
- Truong X. Nguyen, FDA Investigator
- Rumany C. Penn, FDA Investigator
- James A. Barreto, FDA Investigator
- Patricia F. Alberico, FDA Investigator
- Michael D. Kawalek, FDA Investigator